EU Suspends HIV Drug License

Law360, New York (August 8, 2007, 12:00 AM EDT) -- The European Commission has suspended the license for a human immunodeficiency virus treatment made by Roche Pharmaceuticals, after determining that batches of the drug were contaminated during production.

Regulators said Tuesday that they had suspended the marketing authorization for Viracept, an atiretiroviral drug made by Roche and used, as part of a multidrug combination, to treat HIV.

“The suspension follows the contamination of certain batches of Viracept with ethyl mesilate, a genotoxic substance,” the Commission said. “The decision is based on scientific conclusions of the European...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.